Mechanical control of innate immune responses against viral infection revealed in a human Lung Alveolus Chip
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA737154 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR14799344_1.fastq.gz | Fastqsanger.gz | |||
| SRR14799344_2.fastq.gz | Fastqsanger.gz | |||
| SRR14799345_1.fastq.gz | Fastqsanger.gz | |||
| SRR14799345_2.fastq.gz | Fastqsanger.gz | |||
| SRR14799346_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 36 |
Similar Datasets
Project description:Mechanical forces associated with breathing play fundamental role in lung development and disease but the molecular pathways remain largely unknown. Here, we used a mechanically actuatable Human Lung Alveolus Chip that recapitulates human lung alveolar type I and type II cell differentiation, alveolar-capillary interface formation, and genome-wide gene expression profiles characteristic of the distal lung to investigate the role of physical forces associated with cyclic breathing motions in lung innate immune responses to viral infection. When the mechanically active Alveolus Chips are infected with influenza H3N2 virus, a cascade of host responses is elicited on-chip, including increased production of cytokines and expression of inflammation-associated genes in pulmonary epithelial and endothelial cells, resulting in enhanced recruitment of circulating immune cells as occurs during viral infection in vivo. Surprisingly, studies carried out in parallel with static chips revealed that physiological breathing motions suppress viral replication by activating protective innate immune responses in epithelial and endothelial cells. This is mediated at least in part through upregulation of S100 calcium-binding protein A7 (S100A7), which binds to the Receptor for Advanced Glycation End Products (RAGE), an inflammatory mediator that is most highly expressed in the lung alveolus in vivo. This mechano-immunological control mechanism is further supported by the finding that existing RAGE inhibitor drugs can suppress production of inflammatory cytokines in response to influenza virus infection in this model. S100A7-RAGE interactions and modulation of mechanical ventilation parameters could therefore serve as new targets for therapeutic intervention in patients infected with influenza and other potential pandemic viruses that cause life-threatening lung inflammation.
2022-01-01 | GSE177862 | GEO
Project description:Mechanical forces associated with breathing play fundamental role in lung development and disease but the molecular pathways remain largely unknown. Here, we used a mechanically actuatable Human Lung Alveolus Chip that recapitulates human lung alveolar type I and type II cell differentiation, alveolar-capillary interface formation, and genome-wide gene expression profiles characteristic of the distal lung to investigate the role of physical forces associated with cyclic breathing motions in lung innate immune responses to viral infection. When the mechanically active Alveolus Chips are infected with influenza H3N2 virus, a cascade of host responses is elicited on-chip, including increased production of cytokines and expression of inflammation-associated genes in pulmonary epithelial and endothelial cells, resulting in enhanced recruitment of circulating immune cells as occurs during viral infection in vivo. Surprisingly, studies carried out in parallel with static chips revealed that physiological breathing motions suppress viral replication by activating protective innate immune responses in epithelial and endothelial cells. This is mediated at least in part through upregulation of S100 calcium-binding protein A7 (S100A7), which binds to the Receptor for Advanced Glycation End Products (RAGE), an inflammatory mediator that is most highly expressed in the lung alveolus in vivo. This mechano-immunological control mechanism is further supported by the finding that existing RAGE inhibitor drugs can suppress production of inflammatory cytokines in response to influenza virus infection in this model. S100A7-RAGE interactions and modulation of mechanical ventilation parameters could therefore serve as new targets for therapeutic intervention in patients infected with influenza and other potential pandemic viruses that cause life-threatening lung inflammation.
2021-12-01 | GSE178382 | GEO
Project description:Mechanical forces associated with breathing play fundamental role in lung development and disease but the molecular pathways remain largely unknown. Here, we used a mechanically actuatable Human Lung Alveolus Chip that recapitulates human lung alveolar type I and type II cell differentiation, alveolar-capillary interface formation, and genome-wide gene expression profiles characteristic of the distal lung to investigate the role of physical forces associated with cyclic breathing motions in lung innate immune responses to viral infection. When the mechanically active Alveolus Chips are infected with influenza H3N2 virus, a cascade of host responses is elicited on-chip, including increased production of cytokines and expression of inflammation-associated genes in pulmonary epithelial and endothelial cells, resulting in enhanced recruitment of circulating immune cells as occurs during viral infection in vivo. Surprisingly, studies carried out in parallel with static chips revealed that physiological breathing motions suppress viral replication by activating protective innate immune responses in epithelial and endothelial cells. This is mediated at least in part through upregulation of S100 calcium-binding protein A7 (S100A7), which binds to the Receptor for Advanced Glycation End Products (RAGE), an inflammatory mediator that is most highly expressed in the lung alveolus in vivo. This mechano-immunological control mechanism is further supported by the finding that existing RAGE inhibitor drugs can suppress production of inflammatory cytokines in response to influenza virus infection in this model. S100A7-RAGE interactions and modulation of mechanical ventilation parameters could therefore serve as new targets for therapeutic intervention in patients infected with influenza and other potential pandemic viruses that cause life-threatening lung inflammation.
2021-12-01 | GSE178266 | GEO
Project description:Mechanical control of innate immune responses against viral infection revealed in a human Lung Alveolus Chip II
| PRJNA738166 | ENA
Project description:Mechanical control of innate immune responses against viral infection revealed in a human Lung Alveolus Chip III
| PRJNA738808 | ENA
Project description: Not available
| S-EPMC8993817 | biostudies-literature
Project description:Patients with severe influenza-induced lung injury exhibit disrupted alveolar barrier and persistent viral load, accompanied by hyperinflammation, immune cell recruitment, and risk of bacterial superinfection. These complications are often exacerbated in patients undergoing mechanical ventilation. Leveraging an immune-competent human lung alveolus-on-a-chip (Lung Chip) lined by human pulmonary alveolar epithelium co-cultured with monocyte-derived macrophages and interfaced with lung microvascular endothelium, we show that monocyte-derived macrophages play a central role in driving key hallmarks of severe influenza, including activated cell death programs. Physiological strain mimicking breathing motions supported alveolar homeostasis, whereas pathological strain analogous to mechanical ventilator-induced lung overdistension promoted secondary Pseudomonas aeruginosa infection. Computational gene network analysis combined with experimental validation identified SIRT1 as a key modulator of inflammation and susceptibility to bacterial superinfection, which can be mitigated using pharmacological SIRT1 activators. Together, these findings underscore the importance of incorporating macrophages into preclinical models of viral lung injury and establish an integrated workflow combining human Organ Chips and computational approaches for gaining insights into biophysical and molecular disease drivers while facilitating the identification of therapeutic targets and candidate countermeasures.
2026-06-28 | GSE312997 | GEO
Project description:Patients with severe influenza-induced lung injury exhibit disrupted alveolar barrier and persistent viral load, accompanied by hyperinflammation, immune cell recruitment, and risk of bacterial superinfection. These complications are often exacerbated in patients undergoing mechanical ventilation. Leveraging an immune-competent human lung alveolus-on-a-chip (Lung Chip) lined by human pulmonary alveolar epithelium co-cultured with monocyte-derived macrophages and interfaced with lung microvascular endothelium, we show that monocyte-derived macrophages play a central role in driving key hallmarks of severe influenza, including activated cell death programs. Physiological strain mimicking breathing motions supported alveolar homeostasis, whereas pathological strain analogous to mechanical ventilator-induced lung overdistension promoted secondary Pseudomonas aeruginosa infection. Computational gene network analysis combined with experimental validation identified SIRT1 as a key modulator of inflammation and susceptibility to bacterial superinfection, which can be mitigated using pharmacological SIRT1 activators. Together, these findings underscore the importance of incorporating macrophages into preclinical models of viral lung injury and establish an integrated workflow combining human Organ Chips and computational approaches for gaining insights into biophysical and molecular disease drivers while facilitating the identification of therapeutic targets and candidate countermeasures.
2026-06-28 | GSE322591 | GEO
Project description:Patients with severe influenza-induced lung injury exhibit disrupted alveolar barrier and persistent viral load, accompanied by hyperinflammation, immune cell recruitment, and risk of bacterial superinfection. These complications are often exacerbated in patients undergoing mechanical ventilation. Leveraging an immune-competent human lung alveolus-on-a-chip (Lung Chip) lined by human pulmonary alveolar epithelium co-cultured with monocyte-derived macrophages and interfaced with lung microvascular endothelium, we show that monocyte-derived macrophages play a central role in driving key hallmarks of severe influenza, including activated cell death programs. Physiological strain mimicking breathing motions supported alveolar homeostasis, whereas pathological strain analogous to mechanical ventilator-induced lung overdistension promoted secondary Pseudomonas aeruginosa infection. Computational gene network analysis combined with experimental validation identified SIRT1 as a key modulator of inflammation and susceptibility to bacterial superinfection, which can be mitigated using pharmacological SIRT1 activators. Together, these findings underscore the importance of incorporating macrophages into preclinical models of viral lung injury and establish an integrated workflow combining human Organ Chips and computational approaches for gaining insights into biophysical and molecular disease drivers while facilitating the identification of therapeutic targets and candidate countermeasures.
2025-12-07 | GSE272710 | GEO
Project description:Acute exposure to high-dose gamma radiation can result in radiation-induced lung injury (RILI), characterized by acute pneumonitis and subsequent lung fibrosis. A microfluidic organ-on-a-chip lined by human lung alveolar epithelium interfaced with pulmonary endothelium (Lung Alveolus Chip) is used to model acute, early stage RILI in vitro. Both lung epithelium and endothelium exhibit DNA damage, cellular hypertrophy, upregulation of inflammatory cytokines, and loss of barrier function within 6h of radiation exposure, and greater damage is observed in the endothelium. The alveolus chips are exposed to radiation injury at 16 Gy and shows effects that resemble the human lung greater than animal preclinical models. The Alveolus Chip is also used to evaluate the potential ability of two drugs to suppress the effects of acute RILI. These data demonstrate that the Lung Alveolus Chip provides a human relevant alternative approach for studying the molecular basis of acute RILI towards screening radiation countermeasure therapeutics.
2023-09-13 | GSE242706 | GEO